Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced the

BusinessWire_EN 
0 10.01.20
Cidara und Otonomy: Weitere NBC-Favoriten knallen durch die Decke
Cidara und Otonomy: Weitere NBC-Favoriten knallen durch die Decke

Aktien von Cidara Therapeutics (WKN: A14R2R) und Otonomy (WKN: A119VZ) gehörten vergangene Woche mal wieder zu den Gewinnern im Biotech-Sektor. Stehen hier ähnliche Entwicklungen an wie jüngst bei

sharedeals 
0 30.12.19
IVERIC bio: No Brainer Club feiert +486% in 7 Wochen
IVERIC bio: No Brainer Club feiert +486% in 7 Wochen

Die Aktie von IVERIC bio (WKN: A2PHLF) konnte innerhalb der letzten sieben Wochen um +486% von 0,91 USD auf gestern 5,33 USD im Hoch zulegen. Eine Entwicklung, die im exklusiven No Brainer Club so

sharedeals 
0 10.12.19
Novus Therapeutics to Participate in Two Investor Conferences
Novus Therapeutics to Participate in Two Investor Conferences


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced that the

BusinessWire_EN 
0 29.11.19
Heat Biologics: Aktie explodiert - darauf ist jetzt zu achten!
Heat Biologics: Aktie explodiert - darauf ist jetzt zu achten!

Der Aktienkurs von Heat Biologics (WKN: A2JB4Y) erlebt derzeit ein wahres Auf und Ab. Wohin die Reise letztendlich geht, entscheiden die jetzt veröffentlichten Topline-Daten zur

sharedeals 
0 20.11.19
Novus Therapeutics Reports Third Quarter 2019 Financial Results
Novus Therapeutics Reports Third Quarter 2019 Financial Results


Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial

BusinessWire_EN 
0 13.11.19
InflaRx knallt nach Daten-Update – NBC im Partyrausch
InflaRx knallt nach Daten-Update – NBC im Partyrausch

Der „goldene Herbst“ liefert: Nach +400% Kursgewinn mit IVERIC bio (WKN: A2PHLF) schießt mit InflaRx (WKN: A2H7A5) nun ein weiterer NBC-Favorit durch die Decke. Im After-Hours-Handel ging es gestern

sharedeals 
0 07.11.19
IVERIC bio: Warum +370% erst der Anfang sein könnten
IVERIC bio: Warum +370% erst der Anfang sein könnten

Mitglieder des hochexklusiven No Brainer Clubs feiern weiter die Aktie von IVERIC bio (WKN: A2PHLF). Innerhalb der letzten zwei Wochen ging es für den Augenspezialisten an der Börse um zeitweise

sharedeals 
0 05.11.19
No Brainer Club: Weiter geht’s mit +126% Kursgewinn
No Brainer Club: Weiter geht’s mit +126% Kursgewinn

Es ist das, was unserere Experten als den „goldenen Herbst“ bereits vor Wochen angekündigt hatten: Ab Ende Oktober steigen bei den Top-Favoriten des No Brainer Clubs die Kurspartys. Ein Wert sticht

sharedeals 
0 31.10.19
IVERIC bio: No Brainer Club feiert nächste +100%-Party!
IVERIC bio: No Brainer Club feiert nächste +100%-Party!

Der weltweit einzigartige No Brainer Club feiert seinen nächsten Verdoppler: IVERIC bio (WKN: A2PHLF) liefert heute positive Studienergebnisse – das Papier klettert heute um mehr als +100% in die

sharedeals 
0 28.10.19
Sunwin Stevia: Geschäft zieht an – Aktie explodiert!
Sunwin Stevia: Geschäft zieht an – Aktie explodiert!
Dem chinesischen Stevia-Produzenten Sunwin Stevia International (WKN: A1JXDL) ist es gelungen, erstmals schwarze Zahlen zu schreiben. Die Aktie, die derzeit als „Pink Sheet“ an der....
sharedeals 
0 17.09.19
Cidara Therapeutics: Biotech-Schnäppchen knallt nach Mega-Deal
Cidara Therapeutics: Biotech-Schnäppchen knallt nach Mega-Deal
Wieder einmal zeigt sich: Die fetten Deals im Biotech-Sektor werden genau dann gelandet, wenn die Stimmung nahe Tiefpunkt ist: Cidara Therapeutics (WKN: A14R2R) verlor im Laufe des letzten Jahres....
sharedeals 
0 03.09.19
Heat auf Deutschland-Tour: Mehr als Kaffeeklatsch für Bagholders?
Heat auf Deutschland-Tour: Mehr als Kaffeeklatsch für Bagholders?
Große Initiativen bei Heat Biologics (WKN: A2JB4Y): Nach dem kurzzeitigen Kursfeuerwerk mit Gewinnen von zeitweise über +50% im Zuge eines neuen Analysten-Reports Ende vergangenen Monats, will....
sharedeals 
0 08.08.19
Why These Bitcoin Stocks Are Tumbling Today
Why These Bitcoin Stocks Are Tumbling Today
Shares of three stocks, Riot Blockchain (NASDAQ: RIOT), Overstock.com (NASDAQ: OSTK), and Seven Stars Cloud Group (NASDAQ: SSC), that have ridden cryptocurrency mania to explosive gains tumbled on....
TheMotleyFool 
0 22.12.17
Bitcoin Plunges 20% -- Is the Rally Over?
Bitcoin Plunges 20% -- Is the Rally Over?
It's been a tough week for cryptocurrencies in general, and bitcoin in particular. After reaching an all-time high of almost $20,000 just a week ago, bitcoin hit a low of $10,400 on Coinbase....
TheMotleyFool 
0 22.12.17
Ask a Fool: Are Any Bitcoin Stocks Worth Buying?
Ask a Fool: Are Any Bitcoin Stocks Worth Buying?
I consider bitcoin and other digital currencies to be highly speculative investments, and people shouldn't buy them with any money they can't afford to lose.Stocks of companies that could profit....
TheMotleyFool 
0 22.12.17
Why Riot Blockchain Stock Is Soaring... Again
Why Riot Blockchain Stock Is Soaring... Again
Shares of Riot Blockchain (NASDAQ: RIOT) are up 15% as of 12:00 p.m. EST after the company announced it raised a fresh round of capital by selling stock and warrants in a private placement. A....
TheMotleyFool 
0 19.12.17
Bitcoin Stocks: It's the Name That Counts
Bitcoin Stocks: It's the Name That Counts
As the tech sector boomed during the late 1990s, shrewd companies quickly figured out how to send their share prices soaring. If they renamed their company to something that ended with ".com,"....
TheMotleyFool 
0 19.12.17
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Monday was another record-setting day for major benchmarks, which had solid gains of between 0.5% and 1%. Market participants were optimistic that they'll get the corporate tax cuts that they've....
TheMotleyFool 
0 18.12.17
Why Riot Blockchain, Inc Stock Is Soaring on Monday
Why Riot Blockchain, Inc Stock Is Soaring on Monday
Shares of Riot Blockchain (NASDAQ: RIOT) are soaring, rising about 22% as of 12:30 p.m. EST. The company's soaring share price follows the launch of CME's bitcoin futures and a short-lived surge....
TheMotleyFool 
0 18.12.17
Here's Why Marinus Pharmaceuticals Is Soaring Today
Here's Why Marinus Pharmaceuticals Is Soaring Today
Welcome to the popular clique, kid. Shares of clinical-stage biopharma Marinus Pharmaceuticals (NASDAQ: MRNS) rose as much as 22.2% by noon EST after the company announced it will be added to the....
TheMotleyFool 
0 14.12.17
Why Celldex Therapeutics Stock Reversed Course in November
Why Celldex Therapeutics Stock Reversed Course in November
Shares of the struggling small-cap biotech Celldex Therapeutics (NASDAQ: CLDX) finally showed some signs of life in November. Specifically, the biotech's stock rose by a healthy 27.6% last....
TheMotleyFool 
0 10.12.17
3 Top Stocks Under $10
3 Top Stocks Under $10
There's cheap, then there's cheap. Some stocks are cheap in the sense of the definition of the word relating to relatively low price compared to their potential value. Others are cheap under....
TheMotleyFool 
0 10.12.17
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
Better Buy: Ziopharm Oncology Inc. vs. Celldex Therapeutics, Inc.
The American Cancer Society expects 600,920 Americans to die from cancer this year, but Ziopharm Oncology Inc. (NASDAQ: ZIOP) and Celldex Therapeutics, Inc. (NASDAQ: CLDX) aim to lower that....
TheMotleyFool 
0 30.11.17
What You Need to Know About Systematic Risk
What You Need to Know About Systematic Risk
We're a stock-picking company at The Motley Fool, and we tend to sing the praises of investing in individual companies for the long term -- but that's not to say that stock-picking is without its....
TheMotleyFool 
0 29.11.17